Short Term Trading Week Starting: 10 July, page-240

  1. 1,049 Posts.
    lightbulb Created with Sketch. 54
    Thanks for the tag FMF on DXB. Good observations in the chart and well worth paying attention to that second resist area of .017.

    On the FA side, the company is gearing up for the B component of Phase II trials having completed A and release what is largely reported as outstanding results on a NNT basis.

    What we do know is DXB hired Hugh Alsop in May for his Commercial Biotech experience in sealing deals with Big Pharma, so the consensus is that DXB are likely to already to be in talks about licensing or T/O on the back of this recent positive results.

    Lets see what happens.
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.